Evan Loh

Insider Reports History

Entity
Individual
Location
75 Kneeland Street, Boston, MA
Signature
/s/ William M. Haskel, Attorney-in-Fact for Evan Loh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Evan Loh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 28K Mar 1, 2023 Direct
Paratek Pharmaceuticals, Inc. CEO, Director Common Stock 0 $2.20 Sep 21, 2023 Direct

Insider Reports Filed by Evan Loh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRTK Paratek Pharmaceuticals, Inc. Sep 21, 2023 2 $0 4 Sep 21, 2023 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. Aug 8, 2023 2 -$108K 4 Aug 10, 2023 CEO, Director
EIGR Eiger BioPharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
PRTK Paratek Pharmaceuticals, Inc. Dec 20, 2022 2 -$46.7K 4 Dec 22, 2022 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. Dec 12, 2022 2 -$196K 4 Dec 14, 2022 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. Oct 28, 2022 1 -$30.6K 4 Nov 1, 2022 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. Oct 25, 2022 1 $0 4 Oct 27, 2022 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. Aug 8, 2022 2 -$118K 4 Aug 10, 2022 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. Mar 15, 2022 1 $0 4 Mar 23, 2022 CEO, Director
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Director
PRTK Paratek Pharmaceuticals, Inc. Dec 13, 2021 3 -$376K 4 Dec 15, 2021 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. Aug 16, 2021 2 -$174K 4 Aug 18, 2021 CEO, Director
PRTK Paratek Pharmaceuticals, Inc. May 27, 2021 2 -$356K 4 Jun 8, 2021 CEO, Director